Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Spaans JN"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Asmis TR, Ding K, Seymour L, Shepherd FA, Leighl NB, Winton TL, Whitehead M, Spaans JN, Graham BC, Goss GD, National Cancer Institute of Canada Clinical Trials Group
Publikováno v:
Journal of Clinical Oncology; 1/1/2008, Vol. 26 Issue 1, p54-59, 6p
Autor:
Vesikari T; Nordic Research Network Oy, Tampere, Finland., Langley JM; Canadian Center for Vaccinology (Dalhousie University, IWK and Nova Scotia Health), Canada., Spaans JN; VBI Vaccines Inc, Cambridge, MA, United States., Petrov I; VBI Vaccines Inc, Cambridge, MA, United States., Popovic V; VBI Vaccines Inc, Cambridge, MA, United States., Yassin-Rajkumar B; VBI Vaccines Inc, Cambridge, MA, United States., Anderson DE; VBI Vaccines Inc, Cambridge, MA, United States., Diaz-Mitoma F; VBI Vaccines Inc, Cambridge, MA, United States. Electronic address: fdiazmitoma@vbivaccines.com.
Publikováno v:
Vaccine [Vaccine] 2023 Jun 01; Vol. 41 (24), pp. 3584-3588. Date of Electronic Publication: 2023 May 11.
Autor:
Goss GD; The Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.; Division of Medical Oncology, Department of Medicine, The Ottawa Hospital Cancer Center and the University of Ottawa, ON K1N 6N5, Canada., Spaans JN; The Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada., Huntsman D; Imagia Canexia Health, Suite #204 Donald Rix Building, 2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada., Asmis T; Division of Medical Oncology, Department of Medicine, The Ottawa Hospital Cancer Center and the University of Ottawa, ON K1N 6N5, Canada., Andrews Wright NM; The Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada., Duciaume M; The Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada., Kaurah P; Imagia Canexia Health, Suite #204 Donald Rix Building, 2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, and Hereditary Cancer Program, BC Cancer, Vancouver, BC V5Z 4E6, Canada., Miller RR; Imagia Canexia Health, Suite #204 Donald Rix Building, 2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada., Banerji S; CancerCare Manitoba Research Institute, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0V9, Canada., Sekhon HS; The Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.; Department of Pathology, The Ottawa Hospital and the University of Ottawa, Ottawa, ON K1N 6N5, Canada., Gomes MM; The Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.; Department of Pathology, The Ottawa Hospital and the University of Ottawa, Ottawa, ON K1N 6N5, Canada.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Apr 29; Vol. 29 (5), pp. 3171-3186. Date of Electronic Publication: 2022 Apr 29.
Autor:
Vesikari T; Nordic Research Network Ltd, Tampere, Finland., Finn A; Bristol Royal Hospital for Children, Bristol, United Kingdom., van Damme P; University of Antwerp-Center for the Evaluation of Vaccination, Universiteitsplein, Wilrijk, Belgium., Leroux-Roels I; Gent University, Gent, Belgium., Leroux-Roels G; Gent University, Gent, Belgium., Segall N; Clinical Research Atlanta, Stockbridge, Georgia., Toma A; Manna Research, Toronto, Ontario, Canada., Vallieres G; Manna Research, Quebec, Quebec, Canada., Aronson R; LMC Diabetes and Endocrinology, Toronto, Ontario, Canada., Reich D; Medicor Research Inc, Sudbury, Ontario, Canada., Arora S; Aventiv Research, Columbus, Ohio., Ruane PJ; Ruane Clinical Research Group Inc, Los Angeles, California., Cone CL; Montana Medical Research Inc, Missoula., Manns M; Medizinishe Hochschule, Hannover, Lower Saxony, Germany., Cosgrove C; St George's University Hospital NHS Foundation Trust, London, United Kingdom., Faust SN; NIHR Southampton Clinical Research Facility, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, United Kingdom., Ramasamy MN; Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital and University of Oxford, Oxford, United Kingdom., Machluf N; VBI Vaccines Inc, Cambridge, Massachusetts., Spaans JN; VBI Vaccines Inc, Cambridge, Massachusetts., Yassin-Rajkumar B; VBI Vaccines Inc, Cambridge, Massachusetts., Anderson D; VBI Vaccines Inc, Cambridge, Massachusetts., Popovic V; VBI Vaccines Inc, Cambridge, Massachusetts., Diaz-Mitoma F; VBI Vaccines Inc, Cambridge, Massachusetts.
Publikováno v:
JAMA network open [JAMA Netw Open] 2021 Oct 01; Vol. 4 (10), pp. e2128652. Date of Electronic Publication: 2021 Oct 01.
Autor:
Vesikari T; Nordic Research Network, Tampere, Finland., Langley JM; Departments of Pediatrics and Community Health and Epidemiology, Canadian Center for Vaccinology, Halifax, NS, Canada., Segall N; Clinical Research Atlanta, Stockbridge, GA, USA., Ward BJ; McGill University Health Centre-Vaccine Study Centre, Montreal, QC, Canada., Cooper C; Department of Medicine, University of Ottawa, Ottawa, ON, Canada., Poliquin G; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, Canada., Smith B; Department of Mathematics and Statistics, Dalhousie University, Halifax, NS, Canada., Gantt S; BC Children's Hospital Research Institute, University of British Columbia, Vancouver, BC, Canada., McElhaney JE; Health Sciences North Research Institute, Sudbury, ON, Canada., Dionne M; University of Laval, Quebec City, QC, Canada., van Damme P; University of Antwerp-Center for the Evaluation of Vaccination, Universiteitsplein, Wilrijk, Belgium., Leroux-Roels I; Center for Vaccinology, Ghent University, Gent, Belgium., Leroux-Roels G; Center for Vaccinology, Ghent University, Gent, Belgium., Machluf N; VBI Vaccines, Cambridge, MA, USA., Spaans JN; VBI Vaccines, Cambridge, MA, USA., Yassin-Rajkumar B; VBI Vaccines, Cambridge, MA, USA., Anderson DE; VBI Vaccines, Cambridge, MA, USA., Popovic V; VBI Vaccines, Cambridge, MA, USA., Diaz-Mitoma F; VBI Vaccines, Cambridge, MA, USA. Electronic address: fdiazmitoma@vbivaccines.com.
Publikováno v:
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Sep; Vol. 21 (9), pp. 1271-1281. Date of Electronic Publication: 2021 May 11.
Autor:
Diaz-Mitoma F; VBI Vaccines Inc., Cambridge, MA, United States. Electronic address: fdiazmitoma@vbivaccines.com., Popovic V; VBI Vaccines Inc., Cambridge, MA, United States., Spaans JN; VBI Vaccines Inc., Cambridge, MA, United States.
Publikováno v:
Vaccine [Vaccine] 2021 Jun 29; Vol. 39 (29), pp. 3892-3899. Date of Electronic Publication: 2021 Jun 08.
Autor:
Atsmon J; Tel Aviv Sourasky Medical Center, Tel Aviv-Yafo, Israel., Machluf N; SciVac Ltd., Rehovot 7610303, Israel., Yayon-Gur V; SciVac Ltd., Rehovot 7610303, Israel., Sabbah C; SciVac Ltd., Rehovot 7610303, Israel., Spaans JN; VBI Vaccines Inc., Cambridge, MA, United States., Yassin-Rajkumar B; VBI Vaccines Inc., Cambridge, MA, United States., Anderson DE; VBI Vaccines Inc., Cambridge, MA, United States., Popovic V; VBI Vaccines Inc., Cambridge, MA, United States., Diaz-Mitoma F; VBI Vaccines Inc., Cambridge, MA, United States. Electronic address: fdiazmitoma@vbivaccines.com.
Publikováno v:
Vaccine [Vaccine] 2021 Feb 22; Vol. 39 (8), pp. 1328-1332. Date of Electronic Publication: 2021 Jan 13.
Autor:
Weberpals JI; Division of Gynaecologic Oncology, The Ottawa Hospital, Ottawa, Canada. jweberpals@toh.ca.; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Canada., Lo B; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Canada.; Molecular Oncology Diagnostics Laboratory, The Ottawa Hospital, Ottawa, Ontario.; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada., Duciaume MM; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Canada., Spaans JN; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Canada., Clancy AA; Department of Obstetrics and Gynaecology, University of Ottawa, Ottawa, Ontario., Dimitroulakos J; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Canada., Goss GD; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Canada.; Division of Medical Oncology, University of Ottawa, Ottawa, Canada., Sekhon HS; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Canada.; Molecular Oncology Diagnostics Laboratory, The Ottawa Hospital, Ottawa, Ontario.; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Aug 01; Vol. 23 (15), pp. 4501-4510. Date of Electronic Publication: 2017 Apr 04.
Autor:
Clancy AA; Department of Obstetrics and Gynaecology, University of Ottawa, Ottawa, Ontario., Spaans JN; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Ontario., Weberpals JI; Ottawa Hospital Research Institute, Centre for Cancer Therapeutics, Ottawa, Ontario Division of Gynaecologic Oncology, The Ottawa Hospital, Ottawa, Ontario, Canada.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2016 Sep; Vol. 27 (9), pp. 1696-705. Date of Electronic Publication: 2016 Jun 20.